99 filings
Page 3 of 5
EFFECT
k0u1zbbbpbyfdy kz
19 Nov 21
Notice of effectiveness
12:15am
8-K/A
8cxuh s6sjav32vx0
18 Nov 21
Departure of Directors or Certain Officers
5:03pm
CORRESP
8qaga c2fq6n05i1q
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
da81jqlxr2onjkn
15 Nov 21
Letter from SEC
12:00am
S-3
n3eh0134lzj9cdludmv
12 Nov 21
Shelf registration
12:00am
8-K
p41ktyzk
4 Nov 21
Departure of Directors or Certain Officers
4:58pm
8-K
z9m m9gv9
26 Oct 21
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate into Combination
6:54am
8-K
k8hcgve12o9 oe
13 Sep 21
SQZ Biotechnologies Announces First Autoimmune Disease Indication
6:53am
8-K
9977mrx 2g6f6
2 Sep 21
Departure of Directors or Certain Officers
5:00pm
8-K/A
7hjopmi ew4u
29 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
en4 hjc6glfdv2c8ga
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
8-K
8m1mp7vrjmpys
17 Jun 21
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
iz1ey2ssrc
4 Jun 21
Regulation FD Disclosure
8:09am
DEFA14A
23w1 5odn
26 Apr 21
Additional proxy soliciting materials
5:10pm
DEF 14A
iqbmrcld
26 Apr 21
Definitive proxy
5:00pm
10-K
dvpc4ta
18 Mar 21
Annual report
6:31am
8-K
c4o602g
25 Feb 21
Departure of Directors or Certain Officers
5:00pm